Global Health Data Exchange - Discover the World's Health Data

Update on Meningococcal A Vaccine Development and Introduction


General Info
Benin (BEN)
Burundi (BDI)
Chad (TCD)
Eritrea (ERI)
Ethiopia (ETH)
Ghana (GHA)
Guinea (GIN)
Kenya (KEN)
Mali (MLI)
Niger (NER)
Nigeria (NGA)
Rwanda (RWA)
Senegal (SEN)
Sudan (SDN)
Gambia (GMB)
Uganda (UGA)
Coverage type 
Time period covered 
01/2010 - 12/2016

This presentation, delivered at the WHO Product Development for Vaccines Advisory Committee (PD-VAC) meeting, 7-9 September 2015, provides an update from the Meningitis Vaccine Project (MVP), a collaboration between the WHO and PATH dedicated to eliminating epidemic meningitis in sub-Saharan Africa. It covers the introduction and rollout in 26 countries of MenAfriVac, a vaccine developed by the project to protect infants of less than a year to people up to 29 years of age in the African meningitis belt against meningococcal bacterium Neisseria meningitidis group A.